Vera Therapeutics (VERA) EBIAT (2020 - 2026)
Vera Therapeutics posted quarterly EBIAT of -$121.0 million for Q1 2026, down 134.13% year-on-year from $354.6 million in Q1 2025, and down 32.86% on a QoQ basis from -$91.1 million in Q4 2025.
Vera Therapeutics (VERA) has 7 years of EBIAT data on file, last reported at -$121.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBIAT fell 134.13% year-over-year to -$121.0 million; the trailing twelve-month figure through Mar 2026 stood at -$369.0 million (down 110.28% YoY), and the FY2025 full-year result was -$299.6 million, down 96.92% from the prior year.
- EBIAT for Q1 2026 stood at -$121.0 million, down from -$91.1 million in the prior quarter.
- Across five years, EBIAT topped out at -$14.9 million in Q2 2022 and bottomed at -$121.0 million in Q1 2026.
- The 5-year median for EBIAT is -$32.4 million (2022), against an average of -$44.6 million.
- The widest annual swing landed in 2022, when EBIAT tumbled 332.15%; it then grew 20.91% in 2023.
- A 5-year view of EBIAT shows it stood at -$32.4 million in 2022, then rose by 20.91% to -$25.7 million in 2023, then slumped by 69.27% to -$43.4 million in 2024, then sank by 109.78% to -$91.1 million in 2025, then sank by 32.86% to -$121.0 million in 2026.
- The last three EBIAT figures came in at -$121.0 million (Q1 2026), -$91.1 million (Q4 2025), and -$80.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -121.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121.03 Mn |
| Dec 31, 2025 | -91.10 Mn |
| Sep 30, 2025 | -80.29 Mn |
| Jun 30, 2025 | -76.53 Mn |
| Mar 31, 2025 | -51.69 Mn |
| Dec 31, 2024 | -43.43 Mn |
| Sep 30, 2024 | -46.63 Mn |
| Jun 30, 2024 | -33.71 Mn |
| Mar 31, 2024 | -28.38 Mn |
| Dec 31, 2023 | -25.66 Mn |
| Sep 30, 2023 | -20.10 Mn |
| Jun 30, 2023 | -20.16 Mn |
| Mar 31, 2023 | -30.07 Mn |
| Dec 31, 2022 | -32.44 Mn |
| Sep 30, 2022 | -24.68 Mn |
| Jun 30, 2022 | -14.85 Mn |
| Mar 31, 2022 | -17.09 Mn |
| Dec 31, 2021 | -16.85 Mn |
| Sep 30, 2021 | -7.61 Mn |
| Jun 30, 2021 | -3.44 Mn |
| Mar 31, 2021 | -4.71 Mn |
| Dec 31, 2020 | -42.88 Mn |
| Sep 30, 2020 | -4.46 Mn |
| Jun 30, 2020 | -3.60 Mn |
| Mar 31, 2020 | -2.47 Mn |